PLY
Polaryx Therapeutics, Inc. (PLYX) Q4 2025 Annual Earnings
PLYX·Reported March 24, 2026
Diluted EPS came in at $-0.13, missed the $-0.02 consensus by $0.11.
Diluted EPS
$-0.13missed by $0.11
Consensus: $-0.02
Financial Snapshot
Trailing eight quarters through Q4 2025
Q4 2025 Earnings FAQ
Common questions about Polaryx Therapeutics, Inc. 's Q4 2025 earnings report.
Polaryx Therapeutics, Inc. (PLYX) reported Q4 2025 earnings on March 24, 2026.
Polaryx Therapeutics, Inc. reported diluted EPS of $-0.13 for Q4 2025.
EPS missed the consensus estimate of $-0.02 by $0.11.
You can read the 10-K periodic report (0001213900-26-033064) directly on SEC EDGAR. The filing index links above go to sec.gov.